TCRward personalized transplant therapies

Ashima Chadha1, Jonathan S Maltzman1,2

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Science Immunology
|July 7, 2023
PubMed

Insights

Single-cell RNA (scRNA) and T cell receptor (TCR) sequencing of kidney biopsies showed limited T cell clonality during acute cellular rejection. Diverse T cell phenotypes were observed, suggesting complex immune responses in kidney transplants.

Area of Science:

  • Immunology
  • Nephrology
  • Genomics

Background:

  • Acute cellular rejection (ACR) is a major cause of kidney transplant failure.
  • Understanding the T cell repertoire in ACR is crucial for developing targeted therapies.

Purpose of the Study:

  • To characterize the T cell populations and clonality in kidney biopsies from patients with ACR using single-cell sequencing.
  • To investigate the phenotypic diversity of T cells infiltrating the kidney during rejection.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) and T cell receptor sequencing (TCR-seq) were performed on kidney biopsy samples from ACR patients.
  • Bioinformatic analyses were used to identify T cell subsets, assess clonality, and analyze gene expression profiles.

Main Results:

  • Limited T cell clonality was observed in ACR kidney biopsies, indicating a polyclonal T cell response.
  • A diverse range of T cell phenotypes, including effector and regulatory T cells, were identified.
  • Specific T cell subsets were associated with the severity of rejection.

Conclusions:

  • The T cell response in ACR is characterized by limited clonality but diverse phenotypes.
  • These findings highlight the complexity of immune mechanisms in kidney allograft rejection.
  • Further research into specific T cell subsets may lead to novel therapeutic strategies for preventing or treating ACR.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
415
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
69.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K